Primary Record
oxolinic acid
- In stock
- 2,613 g
- Purity
- 99.2 %
- CAS
- 14698-29-4
Compound Identifiers & Properties
- CAS
- 14698-29-4
- PubChem CID
- 4628
- SMILES
- CCN1C=C(C(=O)C2=CC3=C(C=C21)OCO3)C(=O)O
- Canonical SMILES
- CCn1cc(C(=O)O)c(=O)c2cc3c(cc21)OCO3
Names & Synonyms
- oxolinic acid
- Utibid
- Nidantin
- Prodoxal
- Dioxacin
- Emyrenil
- Prodoxol
- Ossian
- Starner
- Pietil
- Uroxol
- 14698-29-4
- Acido oxolinico
- Acide oxolinique
- Gramurin
- Oxolinic
- Uritrate
- Urotrate
- Oksaren
- Ultibid
- Oxoboi
- Uro-alvar
- Acidum oxolinicum
- Aqualinic
- Orthurine
- Cistopax
- Tiurasin
- Urinox
- Uroxin
- Acido ossolico
- oxolinate
- Inoxyl
- oxolinic-acid
- oxolonic acid
- Prodoxol;
- Acid, Oxolinic
- Utibid;
- Oxolinate, Sodium
- Oxolinic Acid-d5
- Aqualinic (TN)
- Oxolinic acid CRS
- quinolone antibiotic
- Acido ossolico [DCIT]
- Oxolinic acid impurity B
- Prestwick_629
- NSC-110364
- C13H11NO5
- Spectrum_001397
- RefChem:55790
- Oxolinic acid impurity A
- AC1L1ILD
- Prestwick0_000193
- Prestwick1_000193
- Prestwick2_000193
- Prestwick3_000193
- Spectrum2_000933
- Spectrum3_001490
- Spectrum4_000073
- Spectrum5_001176
- Acide oxolinique [INN-French]
- Acido oxolinico [INN-Spanish]
- Acidum oxolinicum [INN-Latin]
- CCRIS 6301
- L0A22B22FT
- Lopac-O-0877
- Oxolinic acid (Standard)
- UNII-L0A22B22FT
- DTXSID1021089
- MFCD00056775
- D00MAN
- D0O7CL
- Epitope ID:768770
- HSDB 3243
- AC1Q6E0J
- OXOLINIC ACID [MI]
- W 4565
- CHEBI:138856
- DTXCID101089
- KYGZCKSPAKDVKC-UHFFFAOYSA-N
- Oxolinic acid (USAN/INN)
- OXOLINIC ACID [INN]
- Lopac0_000952
- Oprea1_169598
- SCHEMBL24445
- BSPBio_000145
- BSPBio_003079
- KBioGR_000625
- KBioSS_001877
- OXOLINIC ACID [HSDB]
- OXOLINIC ACID [USAN]
- MLS000028501
- DivK1c_000659
- NSC 110364
- Oxolinic acid [USAN:BAN:INN]
- Oxolinic acid [USAN:INN:BAN]
- SPECTRUM1502030
- EINECS 238-750-8
- SPBio_000866
- SPBio_002066
- NSC110364
- OXOLINIC ACID [MART.]
- BPBio1_000161
- CHEMBL416755
- orb1309290
- orb3025228
- ZINC1875
- Jsp002720
- OXOLINIC ACID [WHO-DD]
- SCHEMBL29420856
- 5-Ethyl-8-oxo-5,8-dihydro-[1,3]dioxolo[4,5-g]quinoline-7-carboxylic acid
- ERK5-2N17
- GTPL12999
- HMS502A21
- HY-B1002R
- KBio1_000659
- KBio2_001877
- KBio2_004445
- KBio2_007013
- KBio3_002579
- KS-00000GUT
- AOB5349
- BRN 0620635
- CID4628
- J01MB05
- MSK5745
- NINDS_000659
- GLXC-06138
- HMS1568H07
- HMS1921F12
- HMS2092P09
- HMS2095H07
- HMS3262P06
- HMS3712H07
- Oxolinic acid, 98% - 5G 5g
- Oxolinic acid, analytical standard
- Pharmakon1600-01502030
- 1-Ethyl-6,7-methylenedioxy-4-quinolone-3-carboxylic acid
- Oxolinic acid, quinolone antibiotic
- SMSSF-0444094
- 5-ethyl-8-oxo-[1,3]dioxolo[4,5-g]quinoline-7-carboxylic acid
- ACT03284
- GRC-6127
- GRC-6211
- HY-B1002
- Tox21_110216
- Tox21_202787
- Tox21_500952
- 5-Ethyl-8-oxo-5,8-dihydro[1,3]dioxolo[4,5-g]quinoline-7-carboxylic acid
- AC8065
- AR-1G8139
- BBF-05909
- BBL009934
- C13-H11-N-O5
- CCG-39666
- NCGC00015762-06
- NSC758177
- OXOLINIC ACID [EP MONOGRAPH]
- S-0208
- s4537
- SBB012469
- STK801351
- W-4565
- AKOS000282622
- Tox21_110216_1
- CS-4499
- DB13627
- EBC-380044
- J8.514F
- LP00952
- LS-7635
- NSC-758177
- SDCCGSBI-0050926.P004
- YF-4604
- CAS-14698-29-4
- IDI1_000659
- NCGC00015762-01
- NCGC00015762-02
- NCGC00015762-03
- NCGC00015762-04
- NCGC00015762-05
- NCGC00015762-07
- NCGC00015762-08
- NCGC00015762-09
- NCGC00015762-10
- NCGC00015762-11
- NCGC00015762-13
- NCGC00015762-17
- NCGC00093361-02
- NCGC00093361-03
- NCGC00093361-04
- NCGC00093361-05
- NCGC00260333-01
- NCGC00261637-01
- 1-Ethyl-1,4-dihydro-6,7-methylenedioxy-4-oxo-3-quinolinecarboxylic acid
- AJ-08105
- AK117020
- AN-17428
- AS-12087
- CN-66706
- SMR000058314
- ST067125
- SY066716
- 5-Ethyl-5,8-dihydro-8-oxo-1,3-dioxolo(4,5-g)quinoline-7-carboxylic acid
- SBI-0050926.P003
- TRPV1 antagonists (pain), Glenmark/Lilly
- AB1009279
- DB-042865
- EU-0100952
- FT-0637128
- NS00010598
- ST24029466
- T7411
- TRPV1 antagonists (asthma), Glenmark/Lilly
- VU0243182-3
- C11342
- D02301
- O 0877
- WLN: T C566 DO FO JN MV EHJ J2 LVQ
- 1,3-Dioxolo(4,5-g)quinoline-7-carboxylic acid, 5-ethyl-5,8-dihydro-8-oxo-
- F3351-0487
- 698O294
- A808577
- F242886
- Q287840
- SR-01000076042
- TRPV1 antagonists (incontinence), Glenmark/Lilly
- 1,3-Dioxolo[4,5-g]quinoline-7-carboxylic acid, 5-ethyl-5,8-dihydro-8-oxo-
- 5-Ethyl-5,8-dihydro-8-oxo-1,3-dioxolo[4,5-g]quinoline-7-carboxylic acid
- I14-7471
- SR-01000076042-1
- SR-01000076042-4
- SR-01000076042-6
- BRD-K73394555-001-08-6
- BRD-K73394555-237-01-1
- 5,8-Dihydro-5-ethyl-8-oxo-1,3-dioxolo[4,5-g]quinoline-7-carboxylic acid
- 5-Ethyl-5,3-dioxolo[4,5-g]quinoline-7-carboxylic acid
- 5-ethyl-8-oxo-5,8-dihydro[1,3]dioxolo[4,5-g]chinolin-7-carbons
- 1-Ethyl-1,7-methylenedioxy-4-oxo-3-quinolinecarboxylic acid
- 16172-03-5
- 5-ethyl-8-oxo-5-hydro-2H-1,3-dioxoleno[4,5-g]quinoline-7-carboxylic acid
- OA
- Oxolinic acid, European Pharmacopoeia (EP) Reference Standard
- 1,5-g]quinoline-7-carboxylic acid, 5-ethyl-5,8-dihydro-8-oxo-
- 5-ethyl-8-oxo-(1,3)dioxolo(4,5-g)quinoline-7-carboxylic acid
- 5-ETHYL-8-OXO-2H,5H,8H-[1,3]DIOXOLO[4,5-G]QUINOLINE-7-CARBOXYLIC ACID
- 1-Ethyl-1,4-dihydro-6,7-methylenebisoxy-4-oxo-3-quinolinecarboxylic acid
- 1.4-Dihydro-1-ethyl-6,7-methylenedioxy-4-oxoquinoline-3-carboxylic acid
- 5-ethyl-8-oxo-5,8-dihydro(1,3)dioxolo(4,5-g)quinoline-7-carboxylic acid
- 5-Ethyl-8-oxo-5,8-dihydro-[1,3]dioxolo[4,5-g]quinoline-7-carboxylicacid
- 5-Ethyl-8-oxo-5,8-dihydro-1,3-dioxolo[4,5-g]quinoline-7-carboxylic acid
- Transient receptor potential vanilloid sub-family 1 (pain), Glenmark/ Lilly
- 5-ETHYL-5,8-DIHYDRO-8-OXO(1,3)DIOXOLO(4,5-G)QUINOLINE-7-CARBOXYLIC ACID
- 5-Ethyl-8-oxo-5,8-dihydro (1,3) dioxolo (4,5-g) quinoline-7-carboxylic acid
- 5-Ethyl-8-oxo-5,8-dihydro-2H-[1,3]dioxolo[4,5-g]quinoline-7-carboxylic acid
- 5-Ethyl-8-oxo-5,8-dihydro[1,3]dioxolo[4,5-g]quinoline-7-carboxylic acid #
- Vanilloid receptor VR1 antagonists (incontinence/pain/asthma), Glenmark/Lilly
- W-4565; 5,8-Dihydro-5-ethyl-8-oxo-1,3-dioxolo[4,5-g]quinoline-7-carboxylic acid
- 10-ethyl-13-oxo-4,6-dioxa-10-azatricyclo[7.4.0.0(3),]trideca-1,3(7),8,11-tetraene-12-carboxylic acid
- 1189890-98-9
- 14954-35-9
- 238-750-8
- 26893-27-6
- InChI=1/C13H11NO5/c1-2-14-5-8(13(16)17)12(15)7-3-10-11(4-9(7)14)19-6-18-10/h3-5H,2,6H2,1H3,(H,16,17
- OXI
- Oxolinic Acid; 1-Ethyl-1,4-dihydro-6,7-methylenedioxy-4-oxo-3-quinolinecarboxylic acid; 1-Ethyl-6,7-methylenedioxy-4-quinolone-3-carboxylic acid; 5-Ethyl-5,8-dihydro-8-oxo-1,3-dioxolo[4,5-g]quinoline-7-carboxylic acid; Dioxacin; Emyrenil; Gramurin; Inoxyl; NSC 110364; Nidantin; Ossian; Oxoboi; Oxolinic acid; Pietil; Prodoxal; Prodoxol; S 0208; Starner; Starner 20WP; Ultibid; Urinox; Uritrate; Uro-Alvar; Urotrate; Uroxin; Uroxol; Utibid; W 4565